PacBio long-read amplicon sequencing enables scalable high-resolution population allele typing of the complex CYP2D6 locus
- Author(s)
- Charnaud, S; Munro, JE; Semenec, L; Mazhari, R; Brewster, J; Bourke, C; Ruybal-Pesántez, S; James, R; Lautu-Gumal, D; Karunajeewa, H; Mueller, I; Bahlo, M;
- Details
- Publication Year 2022-02-25,Volume 5,Issue #1,Page 168
- Journal Title
- Communications Biology
- Abstract
- The CYP2D6 enzyme is estimated to metabolize 25% of commonly used pharmaceuticals and is of intense pharmacogenetic interest due to the polymorphic nature of the CYP2D6 gene. Accurate allele typing of CYP2D6 has proved challenging due to frequent copy number variants (CNVs) and paralogous pseudogenes. SNP-arrays, qPCR and short-read sequencing have been employed to interrogate CYP2D6, however these technologies are unable to capture longer range information. Long-read sequencing using the PacBio Single Molecule Real Time (SMRT) sequencing platform has yielded promising results for CYP2D6 allele typing. However, previous studies have been limited in scale and have employed nascent data processing pipelines. We present a robust data processing pipeline "PLASTER" for accurate allele typing of SMRT sequenced amplicons. We demonstrate the pipeline by typing CYP2D6 alleles in a large cohort of 377 Solomon Islanders. This pharmacogenetic method will improve drug safety and efficacy through screening prior to drug administration.
- Publisher
- NPG
- Research Division(s)
- Population Health And Immunity
- PubMed ID
- 35217695
- Publisher's Version
- https://doi.org/10.1038/s42003-022-03102-8
- Open Access at Publisher's Site
https://doi.org/10.1038/s42003-022-03102-8- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2022-03-15 10:36:46
Last Modified: 2022-03-15 11:16:08